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ANDERSEN SYNDROME
An association of periodic paralysis, cardiac
arrhythmia and dysmorphic abnormalities
Célia H. Tengan1, Antonio C. Antunes1, José R. Bauab1,
Gilmar F. Prado2, Gilberto M. Manzano1, Alberto A. Gabbai1
ABSTRACT - Andersen syndrome (AS) is a rare disease characterized by the presence of periodic paralysis
(PP), cardiac arrhythmia and dysmorphic abnormalities. We re p o rt herein the first Brazilian patient pre-
senting AS who also had obesity, obstructive sleep apnea (OSA) and daytime sleepiness. Clinical and genet-
ic evaluation of six family members demonstrated that four had dysmorphic abnormalities but none had
PP or cardiac arrhythmia. Sequencing of KCNJ2 revealed the R218W mutation in the index patient and her
6 - y e a r-old daughter, who presented dysmorphic abnormalities (micrognathia, clinodactyly of fourth and
fifth fingers, short stature) and OSA. Three relatives had clinodactyly as the only manifestation but the
R218W mutation was absent, suggesting that this characteristic may be influenced by another gene. OSA
accompanied by dysmorphic features may be related to AS. 
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S í n d rome de Andersen: uma associação de paralisia periódica com arritmia cardíaca e alterações
dismórficas
RESUMO - A síndrome de Andersen (SA) é doença rara caracterizada pela presença de paralisia periódica
(PP), arritmia cardíaca e anormalidades dismórficas. Relatamos o primeiro paciente brasileiro apre s e n t a n-
do SA, e que também apresenta obesidade e apnéia obstrutiva do sono (AOS). Avaliações clínica e genéti-
ca de seis familiares demonstraram que quatro apresentavam alterações dismórficas mas nenhum tinha
PP ou arritmia cardíaca. O sequenciamento do gene KCNJ2 revelou a mutação R218W no paciente índex
e sua filha de 6 anos, que apresentava alterações dismórficas (micrognatia, clinodactilia do quarto e quin-
to dedos, baixa estatura) e AOS. Três familiares tinham clinodactilia como única manifestação mas a mutação
R218W estava ausente, sugerindo que esta característica seja influenciada por outro gene. A AOS associa-
da a alterações dismórficas pode estar relacionada à SA. 
PALAVRAS-CHAVE: paralisia periódica, arritmia cardíaca, dismorfismo, apnéia obstrutiva do sono.
Periodic paralyses are a very interesting group of
diseases mainly characterized by recurrent episodes
of flaccid paralysis affecting upper and/or lower limbs.
They are classified in hypokalemic and hyperkalemic
based on serum potassium levels during attacks of
weakness and response to potassium administration1.
Episodic weakness is secondary to abnormalities in
s a rcolemmal excitability due to dysfunctional ion c h a n-
nels. Periodic paralyses are included in the group of
d i s o rders called channelopathies and mutations were
identified in genes coding for sodium ( S C N 4 A )2 , 3, cal-
cium ( C A C N I A S )4 , 5 and potassium( K C N J 2 )6 c h a n n e l s .
A distinct form of periodic paralysis (PP), Andersen
s y n d rome (AS), was recently recognized and charac-
terized by the presence of periodic paralysis (PP), car-
diac arrhythmia (prolonged QT interval or ventricu-
lar arrhythmia) and dysmorphic abnorm a l i t i e s7 , 8. This
disease is caused by a dysfunction of the inward - re c-
tifying potassium channel Kir2.1, and several muta-
tions have already been identified in the gene cod-
ing for this channel, K C N J 26. The presence of develop-
mental abnormalities is the most striking diff e re n c e
f rom other forms of PP, but the contribution of Kir2.1
in bone development remains unexplained. 
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We re p o rtherein a Brazilian patient with AS and
o b s t ructive sleep apnea (OSA). To the best of our
knowledge, this is the first report of AS in Brazil. 
CASE
A 33-year-old Brazilian man complained of episodic
weakness since age of five, with normal muscle stre n g t h
between attacks.  The episodes of weakness had var iable
duration (from minutes to hours) and start ed during re s t
after a period of physical exercise, such as playing soccer,
c a rrying heavy weights. Continuous exercise of mild inten-
sity, such as flexion and extension of the knees, improved
muscle strength during crisis. The affected muscles were
mostly from the legs but with time, arms were also aff e c t-
ed. The frequency of attacks varied according to intensity
and duration of physical exercise. During cold weather, the
attacks were usually more frequent, being everyday in the
worst periods. Other provocative factors, such as fasting or
carbohydrate intake, w ere not re p o rted. The patient did
not complain of muscle pain or cramps. At 13 years of age,
he started with difficulty in climbing stairs even between
attacks. He continued perf o rming daily activities though
he had developed an inter-attack proximal weakness over
the years. He sought medical attention because of exces-
sive daytime sleepiness for the last three years. 
Physical examination revealed: obesity , increased cer-
vical perimeter, weakness of proximal lim b muscles (MRC
grade 4) and dysmorphic abnormalities (micrognathia, re t-
rognathia, clinodactyly of fourth and fifth fingers, short
s t a t u re, arched palate and thoracic scoliosis, Fig 1A). Potas-
sium level was normal in the inter-attack period and dur-
ing spontaneous attacks. Electro c a rdiogram demonstrat-
ed sporadic and isolated ventricular ectopy and pro l o n g e d
QT interval (QTc=490 ms). Nerve conduction studies and
e l e c t romyography were normal with no myotonia. An a b n o r-
mal electrophysiological exercise test confirmed the diag-
nosis of PP, showing a 61.8% decrement of compound mus-
cle action potential (CMAP) amplitudes. 
Polysomnography showed apnea-hypopnea index (AHI)
of 80.2 events/hour, severe oxyhemoglobin desaturation
and periods of ventricular bigeminy (Fig 1B). 
Detection of a previously described mutation in K C N J 2
(R218W) confirmed the diagnosis of AS. No other mutation
was found by sequencing the entire KCNJ2 gene. Clinical
and genetic evaluation of six family members demonstrat-
ed that four had dysmorphic abnormalities but none had
PP or cardiac arrhythmia (Fig 1C). The R218W mutation was
only found in the 6-year-old daughter, who presented dys-
morphic abnormalities (micrognathia, clinodactyly of fourt h
and fifth fingers, short stature) and OSA (AHI=5.2 events/
hour, mild oxyhemoglobin desaturation). The other three
relatives had only a fifth finger clinodactyly.
PP was initially treated with carbonic anhidrase inhibi-
tors (acetazolamide or dichlorphenamide) with decre a s e
in frequency of episodes of weakness but had to be discon-
tinued due to urinary lithiasis. A moderate control of attacks
was achieved with thiazide treatment. After continuous
positive airway pre s s u re(CPAP), polysomnography demon-
strated an improvement of parameters (AHI=16 events/hour,
mild oxyhemoglobin desaturation) and no cardiac arrh y t h-
mia was detected. 
This study was approved by the Ethics Committee of
the Universidade Federal de São Paulo. All participants sign-
ed informed written consent for the research protocols.
DISCUSSION
Although the association of PP, extrasystoles and
multiple developmental anomalies was first report-
ed in 19717, only recently this triad of manifestations
was recognized as a distinct syndrome and named
A S8. Diagnosis of AS may be difficult due to the gre a t
variability in clinical presentation. Moreover the full
s y n d rome is not always pre s e n t9 like in the daugh-
ter's patient, who had only dysmorphic features with-
Fig 1. Main findings in the patient with Andersen syndrome and
o b s t ructive sleep apnea: (A) The patient presented several dys -
morphic features, which included facial dysmorphism (micro g -
nathia and re t rognathia) and clinodactyly. (B) Electro c a rd i o g r a m
re c o rding during polysomnography demonstrated an episode
of ventricular bigeminy. (C) The pedigree shows the subjects
evaluated in this study (*). A KCNJ2 (R218W) was found in the
index patient (III-5) and his daughter (IV-5), both with severe
facial dysmorphic abnormalities, which probably induced the
development of OSA. Clinodactyly of the fifth finger was observ -
ed in the two affected subjects, but was also present in 3 oth -
ers subjects (II-1, III-2, IV-1) not carrying the R218W mutation.
out PP or cardiac abnormalities. A previous study de-
monstrated that only 58% of KCNJ2 mutation carri-
ers presented the full clinical triad while 5% were
nonpenentrant10. The same study showed that ven-
tricular arrhythmias were frequent (64%), syncope
and cardiac arrest were reported but no individuals
suffered sudden cardiac death10.
PP may be associated with hypokalemia, hyper-
kalemia or normokalemia in AS. The type of PP is de-
fined according to the levels of serum potassium dur-
ing crises and characteristics of episodic weakness;
the hypokalemic form is usually provoked by high
carbohydrate intake while the hyperkalemic by fast-
ing or potassium intake. 
A b n o rmalities in serum potassium levels are only
found during attacks, so in the inter-attack period d i a g-
nosis relies on clinical features, provocative tests or
e l e c t rophysiological exercise test. Provocative tests
a re not recommended in AS patients due to the risk
of induction of arrh y t h m i a s9. Regardless of the type
of PP, the diagnosis can be done by an electrophysi-
ological exercise test that typically demonstrates a
p ronounced decrement (>40%) of CMAP amplitude1 1.
Due to the great variability on clinical pre s e n t a-
tion of affected individuals, the diagnosis of AS is es-
tablished in the presence of two of the following
t h ree features: (1) PP; (2) KCNJ2 mutation with elec-
t ro c a rdiographic abnormalities (enlarged U-waves,
ventricular ectopy, nonsustained ventricular tachy-
c a rdia or a prolonged QTc interval); (3) characteris-
tic physical features (at least two of the following:
low-set ears, ocular hypertelorism, small mandible,
fifth digit clinodactyly and syndactyly). A patient with
only one of the features above can be diagnosed
with AS when there is one family member with estab-
lished diagnosis according to the criteria above8 - 1 0 , 1 2.
Our patient and her daughter had manifestations
that fulfilled these criteria but the other three rela-
tives did not and hence could not be considered as
clinically affected, although clinodactyly is one of the
most common dysmorphic features in AS patients12.
After sequencing the entire KCNJ2 gene we exclud-
ed that abnormalities in KCNJ2 would be re s p o n s i-
ble for the development of clinodactyly. Another ge-
ne may be responsible for this feature.
Although our patient presented the full syndro-
me, he only sought medical attention because of a
symptom not typically related to the disease: exces-
sive daytime sleepiness due to OSA. He was first eval-
uated in the sleep disorders clinic and had two well-
known and frequent factors predisposing to OSA,
obesity and craniofacial abnorm a l i t i e s1 3. We re his
manifestations of PP not clear or not well investigat-
ed the diagnosis of AS would probably be missed and
the patient would be considered as having only OSA
due to obesity and craniofacial abnormalities.
The association of AS and OSA was not reported
b e f o re, but one should keep in mind that patients
with craniofacial abnormalities and ventricular arrh y-
thmia during OSA could point out to a mildly aff e c t-
ed individual with AS or individuals with the incom-
plete syndrome.
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